FDAFDA · Food and drugs·Recall number D-0241-2026
Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03
Published December 31, 2025 · Recall initiated: December 12, 2025
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of particulate matter: potential presence of metal particulates in the product.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- EMEND
- Manufacturer
- Merck Sharp & Dohme LLC
- Distributor
- Nationwide in the USA
- Lot
- Lot #: Z014503, Exp 11/15/2027
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.